Genetic profiteering: scandal of firm 'hiding vital breast cancer data':
The company that makes the world's biggest-selling gene test for breast and ovarian cancers is refusing to share groundbreaking knowledge that could benefit patients, academics claim.
Independent
The company that makes the world's biggest-selling gene test for breast and ovarian cancers is refusing to share groundbreaking knowledge that could benefit patients, academics claim.
Independent
No comments:
Post a Comment